tb_knowledge_base = {
    "symptoms": [
        {
            "name": "Persistent Cough",
            "description": "A cough that lasts 3 weeks or longer, often producing mucus or blood. This is one of the most common signs of pulmonary tuberculosis.",
            "keywords": ["cough", "persistent cough", "chronic cough", "blood", "mucus", "sputum"]
        },
        {
            "name": "Fever",
            "description": "Low-grade fever that may come and go, often accompanied by night sweats. Body temperature may range from 99-101°F (37-38°C).",
            "keywords": ["fever", "temperature", "hot", "feverish"]
        },
        {
            "name": "Night Sweats",
            "description": "Excessive sweating during sleep that soaks clothing and bedding. This occurs even in cool environments and is a classic TB symptom.",
            "keywords": ["night sweats", "sweating", "sweat", "drenched", "wet"]
        },
        {
            "name": "Weight Loss",
            "description": "Unexplained weight loss and loss of appetite. People with TB often lose weight without trying, which may be significant over weeks or months.",
            "keywords": ["weight loss", "appetite", "skinny", "thin", "losing weight"]
        },
        {
            "name": "Fatigue",
            "description": "Extreme tiredness and weakness that doesn't improve with rest. This can significantly impact daily activities and quality of life.",
            "keywords": ["tired", "fatigue", "weakness", "exhausted", "weak", "energy"]
        },
        {
            "name": "Chest Pain",
            "description": "Pain in the chest that may worsen with breathing or coughing. This can indicate inflammation in the lungs or surrounding tissues.",
            "keywords": ["chest pain", "breathing pain", "lung pain", "chest hurt"]
        }
    ],
    "treatments": [
        {
            "name": "First-line Anti-TB Drugs",
            "description": "Standard treatment includes 4 medications: Isoniazid, Rifampin, Ethambutol, and Pyrazinamide (HRZE). Treatment typically lasts 6-9 months with an intensive phase (2 months) followed by a continuation phase (4-7 months).",
            "keywords": ["medication", "drugs", "treatment", "isoniazid", "rifampin", "ethambutol", "pyrazinamide"]
        },
        {
            "name": "Directly Observed Therapy (DOT)",
            "description": "A healthcare worker or trained volunteer watches the patient take each dose of medication. This ensures proper adherence and reduces the risk of drug resistance.",
            "keywords": ["DOT", "observed therapy", "supervision", "adherence"]
        },
        {
            "name": "Drug-Resistant TB Treatment",
            "description": "MDR-TB and XDR-TB require specialized treatment with second-line drugs. Treatment may last 12-24 months and includes medications like fluoroquinolones and injectable drugs.",
            "keywords": ["resistant", "MDR", "XDR", "second-line", "drug resistance"]
        },
        {
            "name": "Latent TB Treatment",
            "description": "People with latent TB infection may be treated with isoniazid for 9 months, rifampin for 4 months, or isoniazid and rifapentine for 3 months to prevent active disease.",
            "keywords": ["latent", "prevention", "inactive TB", "LTBI"]
        }
    ],
    "prevention": [
        {
            "topic": "BCG Vaccine",
            "advice": "The Bacille Calmette-Guérin (BCG) vaccine provides protection against severe forms of TB in children. It's given at birth in countries with high TB burden but has variable effectiveness in adults.",
            "keywords": ["vaccine", "BCG", "immunization", "shot"]
        },
        {
            "topic": "Infection Control",
            "advice": "Use proper ventilation, wear N95 masks in high-risk settings, cover mouth when coughing, and isolate infectious patients. UV light and air filtration can help reduce transmission risk.",
            "keywords": ["mask", "ventilation", "isolation", "air", "transmission"]
        },
        {
            "topic": "Contact Screening",
            "advice": "People who have been in close contact with someone with active TB should be tested for infection. This includes family members, coworkers, and healthcare providers.",
            "keywords": ["contact", "screening", "testing", "family", "exposure"]
        },
        {
            "topic": "Risk Factor Reduction",
            "advice": "Maintain good nutrition, manage diabetes, avoid smoking and excessive alcohol, treat HIV appropriately, and maintain good overall health to reduce TB susceptibility.",
            "keywords": ["nutrition", "diabetes", "smoking", "alcohol", "HIV", "immune system"]
        }
    ],
    "general_info": [
        {
            "topic": "What is Tuberculosis",
            "information": "Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis bacteria. It primarily affects the lungs (pulmonary TB) but can affect other parts of the body (extrapulmonary TB). TB is spread through the air when people with active pulmonary TB cough, sneeze, or spit.",
            "keywords": ["what is TB", "tuberculosis", "mycobacterium", "bacteria", "infectious disease"]
        },
        {
            "topic": "TB Transmission",
            "information": "TB spreads through airborne droplets when someone with active pulmonary TB coughs, sneezes, speaks, or sings. You cannot get TB from sharing food, touching surfaces, shaking hands, or other casual contact. Close, prolonged contact with an infectious person increases transmission risk.",
            "keywords": ["spread", "transmission", "contagious", "airborne", "how do you get TB"]
        },
        {
            "topic": "Active vs Latent TB",
            "information": "Latent TB means you're infected but not sick - bacteria are inactive and you can't spread TB. Active TB means bacteria are multiplying, you have symptoms, and may spread TB to others. About 5-10% of people with latent TB develop active TB in their lifetime.",
            "keywords": ["active TB", "latent TB", "inactive", "difference"]
        },
        {
            "topic": "TB Statistics",
            "information": "TB is one of the top 10 causes of death worldwide. In 2022, an estimated 10.6 million people fell ill with TB globally. TB is the leading killer of people with HIV and a major cause of antimicrobial resistance deaths.",
            "keywords": ["statistics", "numbers", "deaths", "global", "worldwide"]
        },
        {
            "topic": "Risk Factors",
            "information": "Higher risk groups include people with HIV, diabetes, malnutrition, those who smoke or use tobacco, people with silicosis, healthcare workers, people in crowded living conditions, and those with weakened immune systems.",
            "keywords": ["risk factors", "who gets TB", "high risk", "vulnerable"]
        },
        {
            "topic": "TB Testing",
            "information": "TB tests include tuberculin skin test (TST), interferon-gamma release assays (IGRAs), chest X-rays, sputum tests, and CT scans. Diagnosis often requires multiple tests to confirm active TB and determine drug sensitivity.",
            "keywords": ["testing", "diagnosis", "skin test", "x-ray", "sputum", "blood test"]
        }
    ]
}
